Cognex (NASDAQ:CGNX) EVP Sells $90,060.00 in Stock

Key Points

• Sheila Marie Dipalma, EVP of Cognex, sold 2,000 shares of the company's stock on September 8th for a total of $90,060, reducing her stake by 23.30%.
• Cognex's stock is currently valued at $44.61 after a slight decline of 0.7%, with an annual dividend yield of 0.7% announced recently.
• Analysts have mixed ratings for Cognex, with a consensus price target of $42.31 and a mix of ratings from "Strong Buy" to "Sell."

Cognex Corporation (NASDAQ:CGNX - Get Free Report) EVP Sheila Marie Dipalma sold 2,000 shares of the firm's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $45.03, for a total transaction of $90,060.00. Following the sale, the executive vice president directly owned 6,582 shares of the company's stock, valued at approximately $296,387.46. The trade was a 23.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Sheila Marie Dipalma also recently made the following trade(s):

• On Friday, September 5th, Sheila Marie Dipalma sold 2,002 shares of Cognex stock. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00.

Cognex Price Performance

CGNX traded down $0.56 during trading hours on Friday, reaching $44.39. 1,405,568 shares of the stock traded hands, compared to its average volume of 1,809,277. The firm's fifty day simple moving average is $39.81 and its two-hundred day simple moving average is $33.04. The company has a market cap of $7.45 billion, a price-to-earnings ratio of 62.52 and a beta of 1.50. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $45.23.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. The company had revenue of $249.09 million during the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period last year, the business earned $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, research analysts predict that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were issued a $0.08 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. Cognex's payout ratio is 45.07%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Osaic Holdings Inc. grew its position in Cognex by 15.4% during the second quarter. Osaic Holdings Inc. now owns 8,352 shares of the scientific and technical instruments company's stock valued at $264,000 after purchasing an additional 1,113 shares in the last quarter. Centaurus Financial Inc. lifted its stake in Cognex by 8.1% in the second quarter. Centaurus Financial Inc. now owns 4,021 shares of the scientific and technical instruments company's stock valued at $128,000 after acquiring an additional 303 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in shares of Cognex by 45.8% in the second quarter. Thrivent Financial for Lutherans now owns 88,043 shares of the scientific and technical instruments company's stock worth $2,792,000 after buying an additional 27,673 shares during the last quarter. Advisory Services Network LLC acquired a new stake in shares of Cognex in the second quarter worth $524,000. Finally, Caxton Associates LLP lifted its stake in shares of Cognex by 66.0% in the second quarter. Caxton Associates LLP now owns 83,242 shares of the scientific and technical instruments company's stock worth $2,640,000 after buying an additional 33,090 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Melius upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price objective on the stock in a research report on Thursday, July 10th. UBS Group lifted their price objective on shares of Cognex from $53.00 to $58.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Robert W. Baird lifted their price objective on shares of Cognex from $30.00 to $32.00 and gave the company a "neutral" rating in a research report on Monday, June 16th. KeyCorp upgraded shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price objective on the stock in a research report on Friday, August 1st. Finally, Citigroup reiterated a "neutral" rating and issued a $37.00 price objective (up from $30.00) on shares of Cognex in a research report on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Cognex presently has a consensus rating of "Moderate Buy" and a consensus target price of $42.31.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.